Laborie Medical Technologies Corp (Laborie) announced the closing of the previously announced acquisition of the JADA System, marking a major milestone in expanding the company's obstetrics portfolio. The addition of the JADA, an FDA-cleared device for the rapid control and treatment of abnormal postpartum uterine bleeding, further reinforces Laborie's commitment to transforming the patient journey through innovative solutions that enhance maternal health and safety.

Joining an obstetrics portfolio that spans antepartum, intrapartum, postpartum, neonatal, and surgical care, the JADA System addresses one of the most urgent challenges in childbirth: postpartum haemorrhage (PPH), the leading cause of maternal mortality worldwide. Each year, millions of women experience PPH, accounting for more than 20 per cent of all maternal deaths.

"The JADA System helps care teams provide treatment during one of the most vulnerable moments of childbirth when every second counts," said Nikki Bruce, Laborie's Vice President and General Manager of OB. "The mission of our Laborie OB business unit has always been to help every mother and newborn go home healthy. This acquisition strengthens that promise and reflects our passion for improving maternal health worldwide."

As part of the acquisition, Laborie will welcome more than 90 new colleagues, primarily in commercial roles.

"The addition of the JADA System and the incredible team behind it marks a tremendous milestone for our OB business and an exciting chapter in Laborie's history," said Laborie President and CEO Chris Smith. "This step forward aligns perfectly with our company's dedication to elevating the standard of care for clinicians and patients."

Backed by multiple clinical studies validating safety and effectiveness, the JADA system uses a low-level vacuum to trigger natural uterine contractions to help stop bleeding quickly and effectively. It has helped more than 136,000 mothers in more than 20 countries, establishing vacuum-induced postpartum haemorrhage care as a recognised standard.

"Patricia Industries is proud to welcome the JADA System and its talented team to Laborie," said Sofia Gerard, Managing Director at Patricia Industries, a part of investor AB and owner of Laborie. "This addition highlights Laborie's dedication to improving maternal health outcomes globally and brings a proven, innovative option that complements our portfolio of technologies in maternal health."